Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Real-World Results of the Single Intravitreal Injection of Faricimab in Treatment-Naïve Subfoveal Myopic Choroidal Neovascularization.

Medicina (Kaunas, Lithuania)·2026
Same author

The Short-Term Outcomes of Intravitreal Faricimab for Treatment-Naïve and -Refractory Neovascular Age-Related Macular Degeneration: A Real-World Study.

Medicina (Kaunas, Lithuania)·2026
Same author

Direct Chemical Reprogramming of Human Fibroblasts into Retinal Progenitor-like Cells for Ocular Delivery.

Journal of functional biomaterials·2026
Same author

Cell Cycle-Specific Regulation of Centrosome Clustering Dynamics in Cancer Cells by the Multifunctional Kinesin HSET.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Ten-Year Registry Analysis of Ocular Inflammation in Taiwan: Distinct Clinical Patterns and Systemic Associations in Adults and Children.

Ocular immunology and inflammation·2026
Same author

HDGF Protects Retinal Pigment Epithelium from Glyoxal-Induced Ferroptosis via SIRT1/PGC-1α/Nrf2 Pathway.

Antioxidants (Basel, Switzerland)·2025

相关实验视频

Updated: Jan 11, 2026

Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy
14:54

Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy

Published on: November 29, 2015

9.0K

双重ROCK1/2-MYLK4激酶抑制在神经炎光学谱障碍光学神经炎的老鼠模型中保持视觉功能.

Chin-Te Huang1,2,3, Monir Hossen1, Tu-Wen Chen1

  • 1Institute of Eye Research, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970473, Taiwan.

Cells
|November 13, 2025
PubMed
概括

一种新型的激酶抑制剂,ITRI-ES,在神经炎光谱障碍 (NMOSD) 鼠标模型中有效治疗视神经炎. 这种治疗保留了视觉功能和视网膜质细胞,为NMOSD患者提供了一个有前途的新治疗途径.

关键词:
神经炎症是一种神经炎症.眼睛神经炎 眼睛神经炎视神经炎是一种视神经炎.蛋白质激酶抑制剂蛋白质激酶抑制剂视网膜质细胞是视网膜质细胞

更多相关视频

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
07:08

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats

Published on: January 10, 2019

10.5K
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.9K

相关实验视频

Last Updated: Jan 11, 2026

Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy
14:54

Rat Model of Photochemically-Induced Posterior Ischemic Optic Neuropathy

Published on: November 29, 2015

9.0K
Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
07:08

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats

Published on: January 10, 2019

10.5K
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.9K

科学领域:

  • 神经科学是一个神经科学.
  • 眼科医生 眼科 眼科
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 神经脊髓炎光谱障碍 (NMOSD) 的特征是严重的视神经炎症和视力丧失.
  • 目前对NMOSD的治疗选择有限,需要开发新的治疗策略.
  • 这项研究研究ITRI-E-(S) 4046 (ITRI-ES),一种双重ROCK1/2和MYLK4激酶抑制剂,用于NMOSD视神经炎.

研究的目的:

  • 评估ITRI-ES在NMOSD诱导的视神经炎的老鼠模型中的治疗疗效.
  • 评估ITRI-ES对视觉功能,视网膜质细胞存活率和视神经炎症的影响.

主要方法:

  • 在使用NMOSD患者血清浸泡海绵的老鼠中诱导了NMOSD类视觉神经炎.
  • 鼠接受了ITRI-ES,酸盐缓冲盐水 (PBS) 或甲基prednisolone (MP) 的静脉内注射.
  • 分析了视觉功能 (fVEP),视网膜质细胞 (RGC) 存活率和亡,以及视神经炎症/脱化标志物.

主要成果:

  • 与PBS相比,ITRI-ES显著保留了视觉功能和RGC密度,同时减少了RGC亡.
  • 通过ITRI-ES治疗维持了水-4 (AQP4) 和髓基蛋白 (MBP) 的较高水平,并抑制了状纤维酸性蛋白 (GFAP).
  • ITRI-ES降低了关键的炎症标志物 (NF-κB,IL-1β,TNF-α) 并促进了抗炎标志物 (Arg1,CD206).

结论:

  • ITRI-ES有效地缓解视神经炎症,并在NMOSD视神经炎中保持视网膜完整性.
  • 双酶抑制剂ITRI-ES显示出显著的神经保护作用并维持视觉功能.
  • 激酶抑制是管理NMOSD相关的视神经炎的有前途的治疗策略.